» Articles » PMID: 20493464

The Value of Infectious Diseases Consultation in Staphylococcus Aureus Bacteremia

Overview
Journal Am J Med
Specialty General Medicine
Date 2010 May 25
PMID 20493464
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Staphylococcus aureus bacteremia results in substantial mortality. Infectious diseases specialist consultation can improve adherence to evidence-based management of S. aureus bacteremia, but its effect on mortality is unclear.

Methods: A 2-year prospective cohort study of patients with S. aureus bacteremia was performed at a large tertiary care hospital. Patients who died within 2 days of diagnosis were excluded. Independent risk factors for 28-day mortality were determined.

Results: Among 341 patients with S. aureus bacteremia, 189 (55%) were male, 196 (58%) were Caucasian, 185 (54%) had methicillin-resistant S. aureus, 108 (32%) had nosocomial bacteremia, and 231 (68%) had a central venous catheter at the time of diagnosis. The median age was 56 years (range 22-95 years). A total of 111 patients (33%) had an infectious diseases consultation. Fifty-four patients (16%) died within 28 days after diagnosis. Factors associated with mortality were intensive care unit admission 48 hours or less after the first positive blood culture (adjusted hazard ratio, 4.65; 95% confidence interval [CI], 2.65-8.18), cirrhosis (adjusted hazard ratio, 4.44; 95% CI, 2.40-8.20), and advanced age (adjusted hazard ratio, 1.27 per every 10 years of age; 95% CI, 1.08-1.50). Infectious diseases consultation was associated with a 56% reduction in 28-day mortality (adjusted hazard ratio, 0.44; 95% CI, 0.22-0.89).

Conclusion: Only one third of patients with S. aureus bacteremia in this cohort had an infectious diseases specialist consultation. Infectious diseases consultation was independently associated with a reduction in 28-day mortality. Routine infectious diseases consultation should be considered for patients with S. aureus bacteremia, especially those with greater severity of illness or multiple comorbidities.

Citing Articles

Current management of bacteremia in a Japanese university hospital.

Hanai S, Yokose M, Harada Y, Doi Y, Shimizu T Fujita Med J. 2024; 10(4):106-110.

PMID: 39494439 PMC: 11528325. DOI: 10.20407/fmj.2024-010.


Routine Infectious Diseases Consultations on a Pediatric Cardiac Unit to Improve Positive Blood Culture Management.

Naureckas Li C, Patel S, Collins C Pediatr Cardiol. 2024; .

PMID: 39134676 DOI: 10.1007/s00246-024-03616-4.


Female Sex and Mortality in Patients with Staphylococcus aureus Bacteremia: A Systematic Review and Meta-analysis.

Westgeest A, Lambregts M, Ruffin F, Korn R, Webster M, Kair J JAMA Netw Open. 2024; 7(2):e240473.

PMID: 38411961 PMC: 10900971. DOI: 10.1001/jamanetworkopen.2024.0473.


A Needs Assessment for Infectious Diseases Consultation in Community Hospitals.

Hollingshead C, Khazan A, Franco J, Ciricillo J, Haddad M, Berry J Infect Dis Ther. 2023; 12(6):1725-1737.

PMID: 37243912 PMC: 10221748. DOI: 10.1007/s40121-023-00810-4.


Impact of specialty on the self-reported practice of using oral antibiotic therapy for definitive treatment of bloodstream infections.

Marcelin J, Keintz M, Ma J, Van Schooneveld T, Alexander B, Bergman S Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e48.

PMID: 36970426 PMC: 10031584. DOI: 10.1017/ash.2023.132.


References
1.
Baddour L, Wilson W, Bayer A, Fowler Jr V, Bolger A, Levison M . Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the.... Circulation. 2005; 111(23):e394-434. DOI: 10.1161/CIRCULATIONAHA.105.165564. View

2.
Malani P, Rana M, Banerjee M, Bradley S . Staphylococcus aureus bloodstream infections: the association between age and mortality and functional status. J Am Geriatr Soc. 2008; 56(8):1485-9. DOI: 10.1111/j.1532-5415.2008.01823.x. View

3.
Chang F, Peacock Jr J, Musher D, Triplett P, MacDonald B, Mylotte J . Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore). 2003; 82(5):333-9. DOI: 10.1097/01.md.0000091184.93122.09. View

4.
Jenkins T, Price C, Sabel A, Mehler P, Burman W . Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008; 46(7):1000-8. DOI: 10.1086/529190. View

5.
Ibrahim E, Sherman G, Ward S, Fraser V, Kollef M . The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000; 118(1):146-55. DOI: 10.1378/chest.118.1.146. View